title: Clozapine therapy throughout myelosuppressive chemotherapy: regulations without standardization.
authors.affiliation: Department of Pharmacy Services, Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA.
authors.forename: Jason N
authors.initials: JN
authors.lastname: Barreto
authors.affiliation: Department of Pharmacy Services, Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA.
authors.forename: Jonathan G
authors.initials: JG
authors.lastname: Leung
authors.affiliation: Department of Psychiatry and Psychology, Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA.
authors.forename: Kemuel L
authors.initials: KL
authors.lastname: Philbrick
authors.affiliation: Department of Psychiatry and Psychology, Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA.
authors.forename: Keith G
authors.initials: KG
authors.lastname: Rasmussen
authors.affiliation: Division of Hematology, Department of Internal Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA.
authors.forename: Carrie A
authors.initials: CA
authors.lastname: Thompson
mesh_terms: D014150:Antipsychotic Agents / Q000627:therapeutic use; D003024:Clozapine / Q000627:therapeutic use*; D006801:Humans; D008223:Lymphoma / Q000188:drug therapy* / Q000453:epidemiology; D008297:Male; D008875:Middle Aged; D017410:Practice Guidelines as Topic / Q000592:standards*; D012559:Schizophrenia / Q000188:drug therapy / Q000453:epidemiology
chemical_list: D014150:Antipsychotic Agents; D003024:Clozapine
keywords: agranulocytosis; chemotherapy; clozapine; clozapine national registry; lymphoma; neutropenia